Search

Pliant Therapeutics Inc

Geschlossen

1.04 -1.89

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.04

Max

1.05

Schlüsselkennzahlen

By Trading Economics

Einkommen

3.5M

-20M

EPS

-0.32

Angestellte

49

EBITDA

8.6M

-20M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+156.73% upside

Dividenden

By Acuity

Nächstes Ergebnis

5. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-7.4M

67M

Vorheriger Eröffnungskurs

2.93

Vorheriger Schlusskurs

1.04

Pliant Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Aug. 2026, 23:51 UTC

Correlated Moves

Bitcoin is trading lower, reflecting a cumulative decline since Friday. The asset is approximately 2.53% below its 20-day moving average.

1. Aug. 2026, 23:01 UTC

The Nikkei 225 Index is trading lower during after-market hours, reflecting a decline from earlier highs and remaining near the lower end of its one-month range.

1. Aug. 2026, 20:01 UTC

Oil (Brent) is trading higher in after-market hours, reflecting strong momentum and remaining above its 20-day moving average. No specific news was identified.

1. Aug. 2026, 20:01 UTC

Correlated Moves

Silver is trading lower in after-market hours, reflecting weakness since Friday's close. The price is near the lower end of its one-month range.

1. Aug. 2026, 20:01 UTC

The DAX 30 Index is trading lower in after-market hours, reversing earlier gains and closing below Friday's level. No specific news was identified.

1. Aug. 2026, 20:01 UTC

Correlated Moves

Gold prices are lower during after-market hours, reflecting unusual price action near the lower end of its one-month range. Silver also declined in tandem.

1. Aug. 2026, 19:11 UTC

Correlated Moves

Avalanche is trading lower during Saturday's session amid a broader cryptocurrency market downturn, with Bitcoin also declining and the asset below its 20-day moving average.

1. Aug. 2026, 19:01 UTC

News
Correlated Moves

Ethereum is trading lower, reflecting a broader decline in correlated assets. It remains below its 20-day moving average amid routine market fluctuations.

1. Aug. 2026, 18:51 UTC

Cardano is trading higher during Saturday's session, reflecting a cumulative gain since Friday. The asset remains above its 20-day moving average.

1. Aug. 2026, 18:41 UTC

Correlated Moves

Ethereum is trading lower today, influenced by declines in Bitcoin. The asset remains near the upper end of its one-month range.

1. Aug. 2026, 18:01 UTC

The Nasdaq 100 Index is lower during after-market hours, declining since Friday's close and trading near the lower end of its one-month range.

1. Aug. 2026, 11:52 UTC

Fed Chair Kevin Warsh's Upcoming Speech Sparks Market Speculation on Interest Rate Changes Amid Rising Inflation Concerns.

1. Aug. 2026, 11:52 UTC

U.S. Nonfarm Productivity Expected to Rise 0.7% in Q2 2026 Amid Mixed Economic Signals

1. Aug. 2026, 11:52 UTC

U.S. Unit Labour Costs Set to Rise 2.7% Amid Strong Wage Growth, Heightening Inflation Concerns Ahead of Federal Reserve Policy Decisions

1. Aug. 2026, 11:51 UTC

Swiss markets closed for National Day; Bitcoin and Ethereum see slight gains, while concerns grow over U.S. stock market reliance on AI-driven stocks and potential Japanese Yen interventions.

1. Aug. 2026, 11:51 UTC

"Bitcoin and Ethereum see gains amid speculation, while U.S. Dollar dips as traders eye key economic data and potential Fed policy shifts."

1. Aug. 2026, 11:51 UTC

Bitcoin and Ethereum see modest gains amid economic uncertainties, while U.S. stock market concentration raises investor concerns and key labor data looms ahead.

1. Aug. 2026, 11:51 UTC

Swiss markets closed for National Day; U.S. stocks rally amid inflation concerns and upcoming key labor data.

1. Aug. 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026 Expected to Show Continued Easing Amid Global Trends.

1. Aug. 2026, 11:41 UTC

U.S. Mortgage Rates Hit One-Year High at 6.66%, Raising Concerns Over Homebuying Demand Ahead of MBA Release on August 5

1. Aug. 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026: Market Anticipates Impact on Economic Policy Amid Mixed Sentiment and External Risks.

1. Aug. 2026, 11:31 UTC

U.S. Exports Data Release on August 4, 2026, Sparks Caution Amid Economic Slowdown and Global Trade Tensions

1. Aug. 2026, 11:31 UTC

U.S. Trade Deficit Expected to Widen to -$73 Billion Amid Rising Imports and Geopolitical Tensions

1. Aug. 2026, 11:22 UTC

U.S. Imports Data Release on August 4 Expected to Show Continued Growth Amid Tariff Distortions and Global Trade Dynamics

1. Aug. 2026, 11:22 UTC

Canada's Balance of Trade expected to show C$3.0 billion surplus amid mixed economic sentiment and external challenges on August 4, 2026.

1. Aug. 2026, 11:22 UTC

Market anticipates 75K job increase in upcoming ADP Employment Change report amid mixed economic signals and cautious optimism.

1. Aug. 2026, 11:02 UTC

Japan's Upcoming Household Spending Report Signals Consumer Caution Amid Mixed Economic Indicators and Retail Disappointment.

1. Aug. 2026, 11:02 UTC

Japan's Household Spending Expected to Rise 0.9% Amid Inflation Concerns and Yen Volatility Ahead of August Release

1. Aug. 2026, 10:51 UTC

Brazil's Central Bank Faces Pressure on SELIC Rate Decision Amid Inflation and Economic Stability Concerns Ahead of August 5th Announcement.

1. Aug. 2026, 10:51 UTC

Mexican Consumer Confidence Index Set for Release Amid Cautious Optimism and Mixed Economic Sentiment on August 4, 2026.

Peer-Vergleich

Kursveränderung

Pliant Therapeutics Inc Prognose

Kursziel

By TipRanks

156.73% Vorteil

12-Monats-Prognose

Durchschnitt 2.67 USD  156.73%

Hoch 3 USD

Tief 2 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pliant Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

5 ratings

1

Buy

4

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
help-icon Live chat